肥胖与非肥胖ARDS机械通气患者躯干倾斜角度的呼吸效应
本二次分析比较了159例机械通气ARDS患者(来自七项独立研究)在增大躯干倾斜角度时的生理变化,其中肥胖患者65例(BMI≥30 kg/m2)、非肥胖患者94例(BMI<30 kg/m2)。增大倾斜角度后,肥胖患者呼吸系统顺应性下降-7.5 [-10; -5] mL/cmH2O(p<0.001),非肥胖患者下降-3.5 [-7; -0.08] mL/cmH2O(p=0.045)。肥胖患者肺顺应性下降-7.8 [-12.4; -3.3] mL/cmH2O(p<0.001),非肥胖患者无显著变化(-5.9 [-14.2; 2.3] mL/cmH2O,p=0.160)。肥胖患者PaCO2升高4.6 [1.4; 7.8] mmHg(p=0.004),非肥胖患者无显著变化(2.5 [-0.6; 5.6] mmHg,p=0.113)。两组PaO2/FIO2在各阶段均无显著差异。作者承认纳入研究存在方法学异质性,可能影响结果,并强调BMI是影响个体对床倾斜角度生理反应的重要变量。
要点
- 肥胖ARDS患者(BMI≥30 kg/m2)增大躯干倾斜角度后呼吸系统顺应性下降-7.5 [-10; -5] mL/cmH2O(p<0.001),降幅大于非肥胖患者的-3.5 [-7; -0.08] mL/cmH2O(p=0.045)。
- 肥胖患者增大倾斜角度后肺顺应性下降-7.8 [-12.4; -3.3] mL/cmH2O(p<0.001),非肥胖患者无显著变化(-5.9 [-14.2; 2.3] mL/cmH2O,p=0.160)。
- 肥胖患者增大倾斜角度后PaCO2升高4.6 [1.4; 7.8] mmHg(p=0.004),非肥胖患者无显著变化(2.5 [-0.6; 5.6] mmHg,p=0.113)。
- 两组胸壁顺应性均下降:肥胖患者-42.9 [-63.2; -22.6] mL/cmH2O(p<0.001),非肥胖患者-47.7 [-95.3; -0.15] mL/cmH2O(p=0.049)。
- 两组PaO2/FIO2在各阶段均无显著差异。
适用人群与场景
- 机械通气合并ARDS的患者,肥胖组BMI≥30 kg/m2(65例),非肥胖组BMI<30 kg/m2(94例)。
- 数据来自七项独立研究,共159例患者。
研究设计与关键结果
- 研究类型:二次分析,比较肥胖与非肥胖机械通气ARDS患者增大躯干倾斜角度时的生理效应,数据来自七项独立研究共159例患者。
- 肥胖患者65例,非肥胖患者94例;增大躯干倾斜角度后,肥胖患者呼吸系统顺应性下降-7.5 [-10; -5] mL/cmH2O(p<0.001),非肥胖患者下降-3.5 [-7; -0.08] mL/cmH2O(p=0.045)。
- 肥胖患者肺顺应性下降-7.8 [-12.4; -3.3] mL/cmH2O(p<0.001),非肥胖患者无显著变化(-5.9 [-14.2; 2.3] mL/cmH2O,p=0.160)。
- 肥胖患者胸壁顺应性下降-42.9 [-63.2; -22.6] mL/cmH2O(p<0.001),非肥胖患者下降-47.7 [-95.3; -0.15] mL/cmH2O(p=0.049)。
- 肥胖患者PaCO2升高4.6 [1.4; 7.8] mmHg(p=0.004),非肥胖患者无显著变化(2.5 [-0.6; 5.6] mmHg,p=0.113)。
- 两组PaO2/FIO2在各阶段均无显著差异。
证据类型、等级与局限
- 证据类型:二次分析(汇总七项独立研究数据)。
- 局限:作者承认纳入研究存在方法学异质性,可能影响结果。
对床旁实践的改变
- 作者认为,BMI是影响个体对床倾斜角度生理反应的重要变量,结果强调在调整躯干倾斜角度时应考虑BMI。
- 在被动通气的ARDS患者中,增大躯干倾斜角度会降低呼吸系统、肺和胸壁顺应性,肥胖患者该效应更明显且PaCO2升高。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Adjusting trunk inclination in patients with acute respiratory distress syndrome directly affects physiological variables such as respiratory mechanics and PaCO2 levels. These effects may vary according to the body mass index (BMI) due to differences in lung and chest wall mechanics, highlighting the need for further investigation to clarify the clinical relevance of body position across patient subgroups.
METHODS: A secondary analysis compared the physiological effects of increasing trunk inclination angles between mechanically ventilated patients with obesity (BMI ≥ 30 kg/m2) and those without obesity (BMI < 30 kg/m2).
RESULTS: Data from 159 patients collected across seven individual studies were analyzed. The following physiological changes were observed in response to increased trunk inclination: Sixty-five patients with obesity presented a greater decrease in respiratory system compliance (-7.5 [-10; -5] mL/cmH2O; p < 0.001) compared to ninety-four patients without obesity (-3.5 [-7; -0.08] mL/cmH2O; p = 0.045). Lung compliance decreased in obese patients (-7.8 [-12.4; -3.3] mL/cmH2O; p < 0.001), whereas no significant changes were observed in patients without obesity (-5.9 [-14.2; 2.3] mL/cmH2O; p = 0.160). Chest wall compliance decreased by -42.9 [-63.2; -22.6] mL/cmH2O (p < 0.001) in obese patients and by -47.7 [-95.3; -0.15] mL/cmH2O in non-obese patients (p = 0.049). PaCO2 increased in obese patients by 4.6 [1.4; 7.8] mmHg (p = 0.004) but not in patients without obesity (2.5 [-0.6; 5.6] (p = 0.113). No significant differences were observed in PaO2/FIO2 between phases.
CONCLUSIONS: Increasing the trunk inclination angle during passive ventilation reduces respiratory system, lung, and chest wall compliance. This effect was more pronounced in obese patients. Moreover, only this population exhibited an increase in PaCO2. We acknowledge the methodological heterogeneity across the included studies, which may have influenced the results. Overall, our results highlight the importance of considering BMI as a significant variable that influences individual physiological responses to changes in bed inclination.
参考来源
- Benites MH, Bihari S, Battiato R, et al. Respiratory effects of trunk inclination in obese and non-obese patients mechanically ventilated for ARDS. Crit Care. 2025. PMID: 41152895. doi:10.1186/s13054-025-05694-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。